Related Experiment Video
Updated: Mar 18, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Coronary artery disease in patients with body mass index ≥30 kg/m(2): a retrospective chart analysis
Hassan Alkhawam1, James Nguyen2, Jason Sayanlar3
1Department of Medicine, Icahn School of Medicine at Mount Sinai, Elmhurst, NY, USA; Hassan.alkhawam@mssm.edu.
Insights
Obesity (BMI ≥30) is a significant risk factor for early coronary artery disease (CAD). Obese patients with additional risk factors like male gender or smoking face a higher likelihood of obstructive CAD.
Area of Science:
- Cardiology
- Public Health
- Obesity Research
Background:
- Coronary artery disease (CAD) remains a leading cause of mortality worldwide.
- Obesity is a growing global health concern with complex associations with cardiovascular diseases.
- Understanding obesity's role as an independent and synergistic risk factor for CAD is crucial for prevention and treatment strategies.
Purpose of the Study:
- To investigate obesity as an independent risk factor for coronary artery disease (CAD).
- To evaluate the synergistic effects of obesity combined with other risk factors on CAD development and severity.
- To identify specific risk factors contributing to obstructive versus non-obstructive CAD in obese individuals.
Main Methods:
- Retrospective analysis of 7,567 patients hospitalized for chest pain between 2005 and 2014.
- Patients categorized into obese (BMI ≥30 kg/m²) and normal (BMI <25 kg/m²) groups.
- Assessment of modifiable and non-modifiable risk factors and the degree of CAD via cardiac catheterization.
Main Results:
- Obesity (BMI ≥30) was identified in 5.5% of patients (414 individuals).
- 80% of obese patients exhibited evidence of CAD, developing it at an average age of 57 compared to 63.3 in non-obese patients (p<0.001).
- In obese patients with CAD, male gender and smoking history were linked to obstructive CAD, while dyslipidemia was associated with non-obstructive CAD. Multiple risk factors correlated with obstructive CAD (p=0.003).
Conclusions:
- A BMI ≥30 is a significant risk factor associated with the earlier onset of CAD.
- The severity of CAD in obese patients is influenced by non-modifiable factors (e.g., male gender) and modifiable factors (e.g., smoking, multiple risk factors).
- Obesity's interplay with other risk factors significantly impacts CAD presentation and progression.
Objective:
In this study, we evaluated obesity as a single risk factor for coronary artery disease (CAD), along with the synergistic effect of obesity and other risk factors.
Methods:
A retrospective study of 7,567 patients admitted to hospital for chest pain from 2005 to 2014 and underwent cardiac catheterization. Patients were divided into two groups: obese and normal with body mass index (BMI) calculated as ≥30 kg/m(2) and <25, respectively. We assessed the modifiable and non-modifiable risk factors in obese patients and the degree of CAD.
Results:
Of the 7,567 patients who underwent cardiac catheterization, 414 (5.5%) had a BMI ≥30. Of 414 obese patients, 332 (80%) had evidence of CAD. Obese patients displayed evidence of CAD at the age of 57 versus 63.3 in non-obese patients (p<0.001). Of the 332 patients with CAD and obesity, 55.4% had obstructive CAD versus 44.6% with non-obstructive CAD. In obese patients with CAD, male gender and history of smoking were major risk factors for development of obstructive CAD (p=0.001 and 0.01, respectively) while dyslipidemia was a major risk factor for non-obstructive CAD (p=0.01). Additionally, obese patients with more than one risk factor developed obstructive CAD compared to non-obstructive CAD (p=0.003).
Conclusion:
Having a BMI ≥30 appears to be a risk factor for early development of CAD. Severity of CAD in obese patients is depicted on non-modifiable and modifiable risk factors such as the male gender and smoking or greater than one risk factor, respectively.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease II: Pathophysiology
Drug Dosing: Obese Patients
Obesity

